Overview
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 3, 2023 | This biotech founder has a new plan to treat Tourette Syndrome, which affects 200,000 Americans each year | Jeff Aronin, CEO of Paragon Biosciences and founder of Emalex Biosciences. Paragon Biosciences Emalex Bioscience is developing a new treatment for Tourette Syndrome. The disease affects around 1 in 160 children and has no cure. Emalex found... |
| Oct 31, 2022 | The Tourette Association of America (TAA) 50th Anniversary Supporting Abilities Gala | "Kids shouldn’t have to go through this or any unkind treatment and it’s now my duty to help educate the next generation so there can be more compassion, more understanding and more guidance for the most important role models kids with... |
| Aug 17, 2020 | I Have Tourette's and He's on the Autism Spectrum. Here's How We Have Sex | This Is How We Do It A series about sex and stigma. See More → When people with neurodevelopmental disorders that affect their social communication capabilities—like Paul and Grace, an older couple who, respectively, have Asperger’s syndrom... |
Reviews 0
FAQ about Tourette Association of America
When was Tourette Association of America founded?
Tourette Association of America was founded in 1972.
What has the press written about Tourette Association of America?
Parsers VC has collected 4 articles mentioning Tourette Association of America, among them “This biotech founder has a new plan to treat Tourette Syndrome, which affects 200,000 Americans each year” (Jan 3, 2023) and “The Tourette Association of America (TAA) 50th Anniversary Supporting Abilities Gala” (Oct 31, 2022).
Is Tourette Association of America still active?
Yes, Tourette Association of America is active; its latest activity on Parsers VC dates from May 29, 2024.